If you use the blue inhaler frequently, wake up coughing at night, or believe your asthma is "controlled" just because attacks happen once in a while, the 2026 GINA update may completely change the way you understand the disease.
The new international GINA (Global Initiative for Asthma) guideline, released in May 2026, brought important changes to asthma treatment, especially regarding the use of the famous rescue inhaler.
And the main message is direct:
Asthma should no longer be treated only when a crisis appears.
Today, specialists from around the world emphasize that asthma inflammation can remain active even when a person "seems fine." This means that many patients considered mild may still have a risk of severe attacks, hospitalizations, and respiratory complications.
What is GINA and why does this update matter?
GINA is a global initiative formed by pneumology and allergy specialists that annually reviews the main scientific studies on asthma worldwide.
GINA recommendations influence:
• doctors
• hospitals
• emergency protocols
• treatments used in offices
• and health policies in various countries
The 2026 update reinforced a change that has been growing over the past few years:
using only a rescue bronchodilator is no longer considered the safest treatment for most asthma patients.
"But I've always used just the rescue inhaler…"
Clinical case: the patient who thought she was controlled
Mariana, 28 years old, used albuterol only when she felt short of breath.
She said:
"My asthma is mild. It only attacks sometimes."
Until a simple flu evolved into an intense crisis, requiring nebulization and a trip to the emergency room.
The problem is that albuterol:
• improves the symptom quickly
• but does not treat lung inflammation
It's like turning off the warning light on the car dashboard without fixing the engine defect.
And that's exactly what GINA 2026 is trying to prevent.
The major change in GINA 2026: treating inflammation from the start
The update reinforces the early use of inhaled corticosteroid medications, even in patients with mild symptoms.
Among the treatments that gained prominence are combinations such as:
• budesonide + formoterol
• inhaled corticosteroid associated with rapid-acting bronchodilator
In practice:
• one medication helps open the lungs
• the other reduces asthma inflammation
And this reduces:
• severe attacks
• need for oral corticosteroids
• hospital visits
• risk of hospitalization
• and even risk of death from asthma
"Does inhaler with corticosteroid cause harm?"
This is still one of the most searched questions on Google.
Clinical case: the patient who was afraid of treatment
Carlos avoided using budesonide because he heard that "corticosteroids cause harm."
So he spent months using a rescue inhaler several times a day.
Result:
• progressive worsening of inflammation
• more wheezing
• more shortness of breath
• more attacks
The big difference is that inhaled corticosteroid acts directly on the lung, in much smaller doses than pills or injections.
That's why, when used correctly and under medical supervision, it is usually safer than living in constant crisis.
Asthma treatment now works in stages
GINA divides asthma into control levels.
The greater the symptoms, the greater the intensity of treatment.
Stage 1: occasional symptoms
Patient who wheezes sometimes or feels short of breath during exercise.
Before:
• rescue inhaler only
Now:
• preference for medications that already control inflammation
Stage 2: frequent symptoms
Nighttime cough, recurrent wheezing, and greater need for rescue inhaler.
This includes:
• low-dose inhaled corticosteroids
• or combination therapy
Stage 3: frequent inhaler use
Patients who start limiting physical activities or have weekly symptoms.
GINA reinforces SMART/MART treatment:
• the same inhaler serves for control and relief
This simplifies treatment and reduces severe attacks.
Stages 4 and 5: moderate and severe asthma
Patients with:
• repeated attacks
• hospitalizations
• constant corticosteroid use
• significant breathing limitation
This may include:
• higher doses of medication
• additional bronchodilators
• and modern biologics
Among them:
• omalizumab
• dupilumab
• mepolizumab
• benralizumab
These treatments represent one of the greatest advances in pneumology in recent years.
Another important change in GINA 2026: children
The update also reinforced new ways to assess the severity of childhood asthma.
This helps doctors quickly identify:
• which children have higher risk
• who needs hospitalization
• and which cases can be safely treated at home
The biggest mistake people with asthma make today
Many people believe that:
"If I only have attacks sometimes, then my asthma is controlled."
But the new guideline makes it clear:
• mild symptoms don't mean low risk
• silent inflammation can still exist
• and relying only on a rescue inhaler can be dangerous
When to see a doctor?
Seek evaluation if you:
• use your rescue inhaler frequently
• wake up coughing
• feel wheezing in your chest
• avoid exercise due to shortness of breath
• have already needed to go to the emergency room
• or have attacks after flu, dust, or climate change
Important
This content is informative and does not replace medical consultation, diagnosis, or individualized treatment.
Each patient has their own characteristics, and the ideal treatment should be defined after proper medical evaluation.
If you experience respiratory symptoms or suspect asthma, see a healthcare professional.
Dr. Rebeca Soares Andrade CRM-GO 39335